44.44000 EUR
0.01
0.02%
Last update Dec 17, 8:00 AM CET
Main market
Day range
44.44000
44.44000
Previous close
44.45000
Open
44.44000
Access this stock data via API
Subscribe
Biomarin Pharmaceutical Inc.
44.44
0.01
0.02%

Statistics

Valuation metrics
Market cap
0
Enterprise value
-289.96M
Trailing P/E (ttm)
19.70
Forward P/E
PEG ratio
Price/Sales (ttm)
0
Price/Book (mrq)
Enterprise Value/Revenue
-0.12
Enterprise Value/EBITDA
-0.53
Overview
Shares outstanding
192.10M
Float
Shares short
% Held by insiders
% Held by institutions
Average volume (10 days)
25
Average volume (90 days)
8
Price summary
52-Week low
44.32
52-Week high
68.72
52-Week change
-40.61 -91.6%
Beta
50-Day moving average
46.32
200-Day moving average
50.54
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Sep 30, 2025
Profitability
Profit margin
79.67%
Operating margin
19.42%
Operational effectiveness
Return on assets
6.11%
Return on equity
7.54%
Income statement
Revenue (ttm)
2.43B
Revenue per share (ttm)
15.02
Quarterly revenue growth (yoy)
-5.97%
Gross profit (ttm)
1.94B
EBITDA
546.04M
Net income to common (ttm)
363.89M
Diluted EPS (ttm)
2.21
Quarterly earnings growth (yoy)
2.63%
Balance sheet
Total cash (mrq)
341.42M
Total cash per share (mrq)
Total debt (mrq)
515.11M
Total Debt/Equity (mrq)
0.10
Current ratio (mrq)
482.76%
Book value per share (mrq)
Cash flow
Cash flow statement
501.31M
Levered free cash flow (LFCF)
1.45B
Access /statistics data via our API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 1 hour

18:59
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).